Clinical Trial

A Study of Surgery and Radiotherapy in People With Breast Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The researchers are doing this study to see if the combination of surgery, locoregional radiation therapy, SBRT (stereotactic body radiation therapy), and the usual approach is more effective in treating oligometastatic HER2-positive breast cancer than the usual approach alone. The researchers will also study the side effects of the study treatment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-06-30; most recent amendment 2026-05-13.
Status change: Not Yet Recruiting → Recruiting 2025-09-18
Trial Details
NCT Number NCT07053085
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: Gateway for Cancer Research
Conditions Metastatic Breast Cancer, HER2-positive Breast Cancer
Enrollment 178 participants
Start Date 2025-09-17
Primary Completion 2029-09-17 (estimated)
Study Completion 2029-09-17 (estimated)
Updated on ClinicalTrials.gov 2026-05-14